Tirzepatide was linked to improved weight loss outcomes in patients with PCOS, especially those who used a digital weight ...

ATLANTA — Tirzepatide appeared highly effective in reducing weight among women with polycystic ovary syndrome (PCOS) and overweight or obesity, real-world data from a retrospective analysis of over ...

CVOT, notable for comparing the two drugs, tirzepatide showed significantly greater improvements in major kidney outcomes vs dulaglutide.

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.

More than 90% of women with polycystic ovary syndrome achieved at least 10% total weight loss after 10 months of tirzepatide ...

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, ...

Tirzepatide's dual mechanism targets GIP and GLP-1, so it provides strong cardiovascular benefits, said Stephen Nicholls, ...

A new database study has found that the injectable weight-loss drugs semaglutide and tirzepatide significantly reduce the ...

Mass General Brigham researchers used real-world data to conduct a head-to-head study to investigate cardioprotective effects, finding both medications reduced risk ...

GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...

A prespecified analysis of the SURPASS-CVOT trial assessed the efficacy and safety of tirzepatide compared with dulaglutide on kidney outcomes in patients with very high-risk CKD and type 2 diabetes.

An IV infusion clinic in Cullman has been court ordered to temporarily close its doors after being accused of administering ...